Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-22T15:51:37.583Z Has data issue: false hasContentIssue false
  • English
  • Français

Poliomyelitis in the Netherlands: a review of population immunity and exposure between the epidemics in 1978 and 1992

Published online by Cambridge University Press:  15 May 2009

H. C. Rümke ,
P. M. Oostvogel ,
G. Van Steenis  and
A. M. Van Loon
H. C. Rümke
Affiliation:
Laboratory for Clinical Vaccine Research, National Institute of Public Health and Environmental Protection(RIVM). PO Box 7, 3720 BA Bilthoven., The Netherlands
P. M. Oostvogel
Affiliation:
Laboratory of Virology, and WHO Collaborative Centre for Reference and Research on Poliomyelitis, National Institute of Public Health and Environmental Protection(RIVM). PO Box 7, 3720 BA Bilthoven., The Netherlands
G. Van Steenis
Affiliation:
Laboratory for the Control of Biological Products, National Institute of Public Health and Environmental Protection(RIVM). PO Box 7, 3720 BA Bilthoven., The Netherlands
A. M. Van Loon
Affiliation:
Laboratory of Virology, and WHO Collaborative Centre for Reference and Research on Poliomyelitis, National Institute of Public Health and Environmental Protection(RIVM). PO Box 7, 3720 BA Bilthoven., The Netherlands
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

An overview of serologieal and virological studies on poliomyelitis in the Netherlands between two epidemics in 1978 and 1992 is given. Three unvaccinated patients acquired poliomyelitis abroad. In the Netherlands vaccination coverage with quadruple DPT–IPV vaccine is very high. The strong immunogenicity of inactivated poliovirus vaccine was confirmed in a cohort of children, reflected in age-stratified antibody profiles of the population. Adults born in the pre vaccination era appeared in general protected, but 10–25% of persons born between 1930 and 1945 lacked neutralizing antibodies. Revaccination induced a booster type of antibody response in 75–90% of such persons, indicating immunological memory and protection.

Virological studies on adopted children from other countries, patients with indications for viral examination, and river waters showed that the Netherlands was regularly exposed to polio virus (PV), without signs of indigenous transmission. Persons found to carry PV or their close contacts had travelled to a PV endemic country. Most of 557 isolates were vaccine-derived, only 8% were wild type viruses. Despite their presence, up to 1992 the well-known susceptibles for PV in the Netherlands were shielded by the herd immunity of the Dutch population.

Type
Research Article
Information
Epidemiology & Infection , Volume 115 , Issue 2 , October 1995 , pp. 289 - 298
Copyright
Copyright © Cambridge University Press 1995

References

1.Bijkerk, H. Surveillance and control of poliomyelitis in the Netherlands. Rev Infect Dis 1984; 6: S451–6.CrossRefGoogle ScholarPubMed
2.Schaap, GJP, Bijkerk, H, Coutinho, RA, Kapsenberg, JG, Van Wezel, AL. The spread of wild poliovirus in the well-vaccinated Netherlands in connection with the 1978 epidemic. Prog Med Virol 1984; 29: 124–40.Google Scholar
3.CDC. Poliomyelitis – Netherlands, 1992. MMWR 1992; 41: 775–8.Google Scholar
4.Oostvogel, PM, Van Wijngaarden, JK.Van der Avoort, HGAM et al. , Poliomyelitis outbreak in an unvaccinated community in the Netherlands, 1992–93. Lancet 1994; 344: 665–70.Google Scholar
5.Verbrugge, HP. The national immunization program of the Netherlands. Pediatrics 1990; 86: S1060–3.Google Scholar
6.Hofman, B. Poliomyelitis in the Netherlands 1958–69: the influence of a vaccination programme with inactivated poliovaccine. Bull WHO 1972; 46: 735–45.Google ScholarPubMed
7.Cohen, H.Hofman, B, Brouwer, R, Van Wezel Al, , Hannik, ChA. Combined inactivated vaccines. Series Immunobiol Standard 1973; 22: 133–41.Google Scholar
8.Van Wezel, AL, Van Steenis, G, Hannik, ChA, Cohen, H. New approach to the production of concentrated and purified inactivated polio and rabies tissues culture vaccines. Develop Biol Standard 1978; 41: 159–68.Google Scholar
9.Furesz, J, Armstrong, RE.Contreras, G. Viral and epidemiological links between poliomyelitis outbreaks in unprotected communities in Canada and the Netherlands. Lancet 1978; ii: 1248.CrossRefGoogle Scholar
10.CDC. Isolation of wild type poliovirus type 3 among members of a religious community objecting to vaccination. Alberta, Canada, 1993. MMWR 1993; 42: 337–9.Google Scholar
11.Oostvogel, PM.Van der Avoort, HGAM, Mulders, MN, Rümke, HC, Van Steenis, G, Van Loon, AM. Virologische en serologische aspecten van de Nederlandse polio-epidemie in 1992. Ned Tijdschr Geneeskd 1993; 137: 1404–6.Google Scholar
12.Conijn-van Spaendonck, MAE, Hannik, ChA, Bijkerk, H et al. , Immuunstatus in 1980 van de Nederlandse bevolking vanaf 10 jaar tegen poliomyelitis, rubella en morbilli; een serologisch onderzoek. Ned Tijdschr Geneeskd 1984; 128: 1884–7.Google Scholar
13.Van der Veer, M, Van Noorle Jansen, LM, Nagel, J, Van Steenis, G, Plantinga, AD, Rümke, HC. Antistofpatronen in een doorsnede van de Nederlandse bevolking. Onderzoek peilstations in 1980 en 1985. 01 1993. RIVM report 927901007.Google Scholar
14.Welp, EAE, Van Steenbergen, JE, Rümke, HC.Van Steenis, G. Beschermingsgraad tegen poliomyelitis van Nederlanders geboren voor 1945 en van allochtonen in de stad Utrecht, en het verband met de sociaal-economische status. Ned Tijdschr Geneeskd 1993; 137: 1388–91.Google Scholar
15.Van Loon, AM.Ras, A, Poelstra, P, Mulders, M, Van der Avoort, H. Intratypic differentiation of polioviruses. In: Measles and poliomyelitis, Kurstak, E, ed. Vienna: Springer Verlag. 1993; 359–69.CrossRefGoogle Scholar
16.Van Olphen, M, Kapsenberg, JG, Van de Baan, E.Kroon, WA. Removal of enteric viruses from surface water at eight waterworks in the Netherlands. Appl Environ Microbiol 1984; 47: 927–32.CrossRefGoogle Scholar
17.Böttiger, M. Polio immunity to killed vaccine: an 18-year follow-up. Vaccine 1990; 8: 443–5.CrossRefGoogle ScholarPubMed
18.Marine, WM, Chin, TDY, Gravelle, CR. Limitations of fecal and pharyngeal poliovirus excretion in Salk-vaccinated children. A family study during a type 1 poliomyelitis epidemic. Am J Hyg 1962; 76: 173–95.Google ScholarPubMed
19.Benyesh-Melnick, M, Melnick, JL.Rawls, WE et al. Studies of the immunogenicity. communicability and genetic stability of oral poliovaccine administered during the winter. Am J Epidemic 1967; 86: 112–36.Google Scholar
20.Onorato, IM.Modlin, JF.McBean, AM.Thorns, ML.Losonsky, GA, Bernier, RH. Mucosal immunity induced by enhanced-potencv inactivated and oral polio vaccines. J Infect Dis 1991; 163: 1–6.Google Scholar
21.Glezen, WP.Lamb, GA, Belden, EA, Chin, TDY. Quantitative relationship of preexisting homotypic antibodies to the excretion of attenuated poliovirus type 1. Am J Epidemiol 1966; 83: 224–37.CrossRefGoogle Scholar
22.Howe, H. The quantitation of poliomyelitis virus in the human alimentary tract with reference to coexisting levels of homologous serum neutralizing antibody. Am J Hyg 1962; 75: 1–17.Google ScholarPubMed
23.Dick, GWA, Danes, DS.McAlister, J, Briggs, M, Nelson, R. Field CMB. Vaccination against poliomyelitis with live virus vaccines. 7. Effect of previous Salk vaccination on virus excretion. BMJ 1961; 2: 266–9.CrossRefGoogle Scholar
24.Expanded Programme on Immunization. Poliomyelitis outbreak-1992. Malaysia. Wkly Epidemiol Rec 1993; 68: 297–300.Google Scholar
25.Kim-Farley, RJ, Rutherford, G, Lichfield, P et al. Outbreak of paralytic poliomyelitis. Taiwan. Lancet 1984; ii: 1322–4.Google Scholar
26.Deming, M.Jaiteh, KO, Otten, MW et al. Epidemic poliomyelitis in The Gambia following the control of poliomyelitis as an endemic disease. Part II: The clinical efficacy of trivalent oral polio vaccine. Amer J Epidemiol 1992; 135: 393–408.CrossRefGoogle ScholarPubMed
27.Sutter, RW.Patriarca, PA.Brogan, S et al. Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children. Lancet 1991; 338: 715–20.Google Scholar
28.Wright, PF.Kim-Farley, RJ, De Quadros, CA et al. Strategies for the global eradication of poliomyelitis by the year 2000. N Engl J Med 1991; 325: 1774–9.CrossRefGoogle ScholarPubMed
29.Hull, HF.Ward, NA, Hull, BP.Milstien, JB.de Quadros, C. Paralytic poliomyelitis: seasoned strategies, disappearing disease. Lancet 1994; 343: 1331–7.Google Scholar
30.Moriniere, BJ.Van Loon, FPL.Rhodes, PH et al. Immunogenicity of a supplemental close of oral versus inactivated poliovirus vaccine. Lancet 1993; 341: 1545–50.CrossRefGoogle Scholar
31.Patriarca, PA.Foege, WH.Swartz, TA. Progress in polio eradication. Lancet 1993; 342: 1461–4.CrossRefGoogle ScholarPubMed